UPDATE 1-Biogen, AbbVie once-monthly MS injection wins U.S. approval

May 27 (Reuters) - The U.S. Food and Drug Administration on

Friday approved a once-monthly injection for multiple sclerosis

from Biogen Inc and AbbVie Inc, with a boxed

warning.

Read more